Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating beta blocker use in traumatic brain injury stratified by high-sensitivity troponin T status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Trauma, Brain Injuries | Phase 4 | Status: UNKNOWN